Abstract
The PRDM family of methyltransferases has been implicated in cellular proliferation and differentiation and is deregulated in human diseases, most notably in cancer. PRDMs are related to the SET domain family of methyltransferases; however, from the 19 PRDMs only a few PRDMs with defined enzymatic activities are known. PRDM15 is an uncharacterized transcriptional regulator, with significant structural disorder and lack of defined small-molecule binding pockets. Many aspects of PRDM15 are yet unknown, including its structure, substrates, reaction mechanism, and its methylation profile. Here, we employ a series of computational approaches for an exploratory investigation of its potential substrates and reaction mechanism. Using the knowledge of PRDM9 and current knowledge of PRDM15 as basis, we tried to identify genuine substrates of PRDM15. We start from histone-based peptides and learn that the native substrates of PRDM15 may be non-histone proteins. In the future, a combination of sequence-based approaches and signature motif analysis may provide new leads. In summary, our results provide new information about the uncharacterized methyltransferase, PRDM15.
Funder
IngaBritt och Arne Lundbergs Forskningsstiftelse
Crafoord Foundation
Åke Wibergs Stiftelse
Swedish Research Council
Swedish Cancer Society
the Faculty of Medicine, Lund University, the Swedish Foundation for Strategic Research
Strategic Research Area EXODIAB
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference39 articles.
1. Transcription factors: An overview;Latchman;Int. J. Exp. Pathol.,1993
2. Too many transcription factors: Positive and negative interactions;Karin;New Biol.,1990
3. Transcriptional Addiction in Cancer;Bradner;Cell,2017
4. Wang, J., Liu, Q., and Shyr, Y. (2015). Dysregulated transcription across diverse cancer types reveals the importance of RNA-binding protein in carcinogenesis. BMC Genom., 16.
5. Targeting transcription factors in cancer—From undruggable to reality;Bushweller;Nat. Rev. Cancer,2019